Home › Studies › PRJNA810891
PRJNA810891 SRP361707

Fecal microbiome & GVHD severity in allo-HCT, New York

Preservation of fecal microbiome is associated with reduced severity of Graft-versus-Host Disease

Cross-sectional study of 173 fecal samples from adult allogeneic hematopoietic cell transplant (allo-HCT) patients in New York, USA, examining microbiome dysbiosis in relation to graft-versus-host disease (GVHD) onset and severity. machine-written summary

173 samples · 280 runs · US · Adult · 2022 · 4.62 Gbp / sample

Sources
✓Sequence archive 1,223–Abstract / description–Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive1,223 sample values (country, health condition, health condition detail, latitude, location region, longitude, subject id, timepoint)
– Abstract / descriptionno abstract or project description
– Full textno open-access full text linked
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 sampling locations · 1 country
Age
adult173
Condition
transplant_or_immunocompromised173
Country
US173
Body site
primary173
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 1 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 3 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 37 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 122 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 10 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 4.63 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolved

30 of 126 people sampled more than once (76 samples; median 2, up to 5 per person). Schedule stated by the source: “Multiple timepoints per subject; 9 distinct timepoints recorded (labels: 2, 3, 6, 7, 8, 10, 14, 15). 30 subjects sampled more than once.”.

How longitudinal and relatedness information is derived

Community composition
Enterococcus_B 19.4%Streptococcus 7.4%Bacteroides 4.9%Lacticaseibacillus 3.4%Escherichia 3.3%Phocaeicola 3.3%Klebsiella 3.2%Enterocloster 2.7%Akkermansia 2.5%Blautia 2.5%Veillonella 2.4%Thomasclavelia 2.2%not assigned to a genus 3.5%other genera 39.4%

Genera, mean relative abundance over 155 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category173 100%
country173 100%173
health_condition173 100%173
subject_id172 99%172
detailed_location173 100%
health_condition_detail173 100%173
latitude173 100%173
location_region173 100%173
longitude173 100%173
timepoint_label13 8%13
Details
Archive description

Patterns of microbial dysbiosis can be detected in fecal samples of GI-aGVHD patients peri-aGVHD onset. Markers of microbial health pre-GVHD onset are associated with longer survival and lower risk of GVHD-related mortality after allo-HCT.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by sonnet_x2 with confidence 0.68. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • body site run.scientific_name · “human gut metagenome”
  • life stage study.description · “allo-HCT”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN07491337countryUSR10.90sample.attr.geo_loc_nameUSA:New York
SAMN07491337health_conditiontransplant_or_immunocompromisedR10.85ena.experiment_titleStool sample of allo-HCT patient
SAMN07491337health_condition_detailallo-HCT patientR10.85ena.experiment_titleStool sample of allo-HCT patient
SAMN07491337latitude40.7641R10.90biosample.attribute:lat_lon40.7641 N 73.9568 W
SAMN07491337location_regionNew YorkR10.85biosample.attribute:geo_loc_nameUSA:New York
SAMN07491337longitude-73.9568R10.90biosample.attribute:lat_lon40.7641 N 73.9568 W
SAMN07491337subject_id1066R10.85sample.attr.patient_id1066
SAMN13270923subject_id1015R10.70biosample.name_rule:sample_id_unique1015G
SAMN12007735timepoint_label10R10.85sample.attr.bmtday10
Sequencing

280 runs over 280 samples · mean 5.09 Gbp per run (median 4.62 Gbp, total 1,426.18 Gbp; 280 runs with a base count) · layout PAIRED 280 · platform ILLUMINA 280 · models Illumina HiSeq 4000 (280) · 89% of runs with a Sandpiper profile · first public 2022-06-20 – 2022-06-21

Authors (0)

No author record.

Downloads

PRJNA810891.csv.gz (5.7 KB) · parquet (77.5 KB) — all 173 samples, every field with route and confidence · PRJNA810891_determinations.csv.gz (10.3 KB) — 1,223 evidence rows

Samples (173 · every field this project has values for · hover a cell for its source)
Loading the sample table…